Thomas J et al. |
The immunosuppressive action of FK506. In vitro induction of allogeneic unresponsiveness in human CTL precursors. |
1990 |
Transplantation |
pmid:1689518
|
Andrades KM et al. |
Modulation of Candida albicans virulence by antirejection immunosuppressant drugs. |
2013 |
Transplantation |
pmid:23380869
|
Faguer S et al. |
Rituximab therapy for acute humoral rejection after kidney transplantation. |
2007 |
Transplantation |
pmid:17496547
|
Mañez R et al. |
Fluconazole therapy in transplant recipients receiving FK506. |
1994 |
Transplantation |
pmid:7515201
|
Sakr M et al. |
Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients. |
1992 |
Transplantation |
pmid:1373535
|
Hirano Y et al. |
Morphological and functional changes of islets of Langerhans in FK506-treated rats. |
1992 |
Transplantation |
pmid:1373536
|
Pescovitz MD et al. |
Prospective observational study of sirolimus as primary immunosuppression after renal transplantation. |
2009 |
Transplantation |
pmid:19855247
|
Miroux C et al. |
In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function. |
2012 |
Transplantation |
pmid:22743548
|
Stegall MD et al. |
Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine. |
1997 |
Transplantation |
pmid:9422404
|
Larsen JL et al. |
Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats. |
2006 |
Transplantation |
pmid:16926589
|
Petruzzo P et al. |
The International Registry on Hand and Composite Tissue Transplantation. |
2010 |
Transplantation |
pmid:21052038
|
de Graav GN et al. |
A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation. |
2017 |
Transplantation |
pmid:28403127
|
Watanabe M et al. |
Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance. |
2013 |
Transplantation |
pmid:23860082
|
Atkison PR et al. |
Arteritis and increased intracellular calcium as a possible mechanism for tacrolimus-related cardiac toxicity in a pediatric transplant recipient. |
1997 |
Transplantation |
pmid:9311719
|
Yamamoto S et al. |
FK778 and FK506 combination therapy to control acute rejection after rat liver allotransplantation. |
2004 |
Transplantation |
pmid:15591950
|
Tan HP et al. |
Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience. |
2004 |
Transplantation |
pmid:15591960
|
Hadley S et al. |
Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. |
1995 |
Transplantation |
pmid:7535482
|
Mahé E et al. |
Drug-induced hypersensitivity syndrome associated with primary Epstein-Barr virus and human herpesvirus 6 infections in a child intestinal transplant recipient. |
2004 |
Transplantation |
pmid:14966435
|
Paramesh AS et al. |
Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation. |
2004 |
Transplantation |
pmid:14724447
|
Alessiani M et al. |
Combined immunosuppressive therapy with tacrolimus and mycophenolate mofetil for small bowel transplantation in pigs. |
1996 |
Transplantation |
pmid:8830816
|
Gallon L et al. |
ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients. |
2006 |
Transplantation |
pmid:16477235
|
Boillot O et al. |
Reversal of early acute rejection with increased doses of tacrolimus in liver transplantation: a pilot study. |
1998 |
Transplantation |
pmid:9825815
|
Sanchez EQ et al. |
Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. |
2010 |
Transplantation |
pmid:20098288
|
Jain AB et al. |
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. |
1998 |
Transplantation |
pmid:9825817
|
Niioka T et al. |
Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation. |
2012 |
Transplantation |
pmid:23073468
|
Miyazawa H et al. |
Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition. |
1995 |
Transplantation |
pmid:7537396
|
Sureshkumar KK and Chopra B |
In search of an optimal induction agent in kidney transplantation. |
2014 |
Transplantation |
pmid:24978038
|
Welberry Smith MP and Baker RJ |
The author's reply. |
2014 |
Transplantation |
pmid:24978039
|
Buell JF et al. |
Malignancy after transplantation. |
2005 |
Transplantation |
pmid:16251858
|
Hariharan S |
Case 2: strategies to minimize the use of calcineurin inhibitors (CNIs). |
2002 |
Transplantation |
pmid:12357988
|
Zaltzman JS |
A comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily cyclosporine on renal function in healthy volunteers. |
2010 |
Transplantation |
pmid:21166111
|
Ueda M et al. |
A proposal of FK506 optimal dosing in living related liver transplantations. |
1995 |
Transplantation |
pmid:7544035
|
Aw MM et al. |
Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience. |
2003 |
Transplantation |
pmid:12660504
|
Ellis D et al. |
Phospholipase-C and Na-K ATPase activation by cyclosporine and FK506 in LLC-PK1, cells. Possible implications in blood pressure regulation. |
1991 |
Transplantation |
pmid:1714643
|
Mathew A et al. |
Reversal of steroid-resistant rejection in renal allograft recipients using FK506. |
1995 |
Transplantation |
pmid:7482730
|
MacDonald AS |
Impact of immunosuppressive therapy on hypertension. |
2000 |
Transplantation |
pmid:11152235
|
Gillard P et al. |
Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy. |
2014 |
Transplantation |
pmid:24770614
|
Gruessner RW et al. |
Portal donor-specific blood transfusion and mycophenolate mofetil allow steroid avoidance and tacrolimus dose reduction with sustained levels of chimerism in a pig model of intestinal transplantation. |
2004 |
Transplantation |
pmid:15239611
|
Bazerbachi F et al. |
Pancreas-after-kidney versus synchronous pancreas-kidney transplantation: comparison of intermediate-term results. |
2013 |
Transplantation |
pmid:23183776
|
Gralla J and Wiseman AC |
The impact of IL2ra induction therapy in kidney transplantation using tacrolimus- and mycophenolate-based immunosuppression. |
2010 |
Transplantation |
pmid:20595929
|
Glotz D et al. |
Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids. |
2010 |
Transplantation |
pmid:20386144
|
Sher LS et al. |
Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. |
1997 |
Transplantation |
pmid:9256184
|
Yuzawa K and Fukao K |
Topical FK506 ointment for skin grafting. |
1998 |
Transplantation |
pmid:9565111
|
Margreiter R et al. |
A double-hand transplant can be worth the effort! |
2002 |
Transplantation |
pmid:12134104
|
Opelz G and Döhler B |
Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients. |
2011 |
Transplantation |
pmid:21452411
|
Veenhof H et al. |
Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients. |
2017 |
Transplantation |
pmid:27906832
|
Miura Y et al. |
Factors increasing quantitative interstitial fibrosis from 0 hr to 1 year in living kidney transplant patients receiving tacrolimus. |
2011 |
Transplantation |
pmid:21452412
|
MacPhee IA and Holt DW |
A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype. |
2008 |
Transplantation |
pmid:18212618
|
Cezário ES et al. |
Gingival overgrowth in renal transplant subjects medicated with tacrolimus in the absence of calcium channel blockers. |
2008 |
Transplantation |
pmid:18212628
|
Tourret J et al. |
Immunosuppressive Treatment Alters Secretion of Ileal Antimicrobial Peptides and Gut Microbiota, and Favors Subsequent Colonization by Uropathogenic Escherichia coli. |
2017 |
Transplantation |
pmid:27681266
|